Cellectar Biosciences, Inc. (CLRB)
Market Closed
14 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
2. 31
0
0%
$
18.46M Market Cap
- P/E Ratio
- Div Yield
65,700 Volume
-3.91 Eps
$ 2.31
Previous Close Want to track CLRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Cellectar Biosciences, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| ABB Alexander Bjornager Bonde Danske Bank A/S | 2 | $14 | $4.62 | -$9.38 | -67% |
 Kevin Roan Stempoint Capita LLP | 354,938 | $883,795.62 | $827,005.54 | -$56,790.08 | -6.43% |
 Joseph Gentili Riverview Capital Advisers LLC | 10,384 | $73,830.24 | $24,194.72 | -$49,635.52 | -67.23% |
 Kevin Bresler TD Waterhouse Canada Inc. | 63 | $181 | $161.91 | -$19.09 | -10.55% |
 Zachary Canonico DIADEMA PARTNERS LP | 138,341 | $344,469.09 | $359,686.6 | $15,217.51 | 4.42% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 92,983 | $231,527.67 | $223,159.2 | -$8,368.47 | -3.61% |
